Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid raft microdomains are specialized, highly ordered regions of the cell membrane enriched in cholesterol, sphingolipids, and saturated phospholipids. They function as dynamic platforms that organize and concentrate signaling molecules, such as G protein-coupled receptors and tyrosine kinases, to facilitate efficient cellular communication and intracellular trafficking (Simons & Sampaio, 2011). In malignant cells, these microdomains are often upregulated or structurally altered, providing a scaffold for oncogenic signaling pathways like PI3K/Akt and Ras/MAPK that promote uncontrolled proliferation, survival, and epithelial-mesenchymal transition (Greenlee et al., 2021). Targeting lipid rafts has emerged as a novel therapeutic strategy, utilizing agents like alkylphospholipids (e.g., edelfosine) that selectively accumulate in cancer cell rafts to induce apoptosis by reorganizing death receptors or inhibiting survival signals (Mollinedo & Gajate, 2015). Despite their potential, the primary challenge in targeting these domains lies in achieving selectivity for tumor cells over healthy tissues to minimize systemic toxicity (Li et al., 2022).
Disruption of membrane microdomain structural integrity through cholesterol depletion or lipid analog incorporation, leading to the modulation of raft-resident oncogenic signaling pathways and induction of apoptosis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid raft microdomain (LR).